FDA estimate “simply perpetuates the agency’s previous misunderstanding of the burden that NDI notifications impose,” says CRN CEO Steve Mister. FDA says its estimate is for costs of submitting information, not for studies to generate the information.

China's historic antitrust fine against Alibaba indicates regulatory attention to anticompetitive practices is mounting. Past cases show the pharma sector is not immune and while it remains segmented, investigators appear to be taking a generally more sophisticated approach to transgressions. 

Natural Adventure and PYRLess Group are latest firms to learn FDA, FTC continue monitoring the market for claims promoting supplements as COVID-19 treatments. Hi-Tech Pharmaceuticals recalls APS Nutrition Isomorph 28 and iForce Nutrition Mass Gainz due to undeclared allergens.

FDA is conducting lab testing on CBD products with funding in its FY2021 appropriations, says senior agency advisor Sharon Mayl. Some work planned work in the area has been delayed by the agency's response to COVID-19.

Former FDA commissioner says legislative carve-out for a regulatory pathway for cannabinoids is a better option than a rulemaking, which could take five years and “may not even work.” Cannabinoids market is “well far ahead of where the regulation is,” he says.

“Irrational exuberance was an understatement for what people thought of the CBD market in 2018 and 2019,” says an attorney specializing in hemp regulations. In 2019, CBD isolate could be sold for “upwards of $12,000 a kilogram,” but price now is less than $1,000.

P&G has snapped up leading Australian effervescent vitamins brand Voost, which is said to have “high affinity amongst millennials” and a presence in select international markets.

Belgium's Vision Healthcare - led by Yvan Vindevogel - has strengthened its growing European e-commerce platform with the acquisition of Slovenia's Sensilab.

The latest European consumer health business news: France's Mayoly Spindler acquires Italian supplements specialist Biohealth; UK-based Flarin gets funding to expand at home and abroad; and Sweden's Karo plots further M&A in 2021.

For more than 20 years, SGS’s Chemical Solutions Laboratories focused on heavy metals, minerals and trace elemental testing. With expanded capability, the Harrisburg facility also offers testing services for vitamins; amino acids; pesticide residues; microorganisms; solvent residues; and label claims.

US consumer health sales jumped 6.7% in 2020 in stores, a reversal of recent years as consumers move away from private label, “on-the-go” and natural oral care during the pandemic, IRI data show.

P&G has snapped up leading Australian effervescent vitamins brand Voost, which is said to have “high affinity amongst millennials” and a presence in select international markets.

Stada has entered the US dietary supplements category following significant gains for its Branded Products business in 2020. Acquisitions helped to drive up Branded Products sales by 27% last year, enabling Stada to become a top-five player in Europe's consumer health market. 

The latest European consumer health news: Germany's Bionorica posts double-digit sales decline due to COVID; Precision Healthcare takes Kwai to Austria; and Alfasigma hires Janssen exec to lead expanded Italy business.

Enjoying a 5% sales rise, Bayer Consumer Health grew faster than the global market last year, with the company keen to repeat the performance in 2021.

China's historic antitrust fine against Alibaba indicates regulatory attention to anticompetitive practices is mounting. Past cases show the pharma sector is not immune and while it remains segmented, investigators appear to be taking a generally more sophisticated approach to transgressions. 

Natural Adventure and PYRLess Group are latest firms to learn FDA, FTC continue monitoring the market for claims promoting supplements as COVID-19 treatments. Hi-Tech Pharmaceuticals recalls APS Nutrition Isomorph 28 and iForce Nutrition Mass Gainz due to undeclared allergens.

With FSA set to publish its public register detailing which CBD supplements can lawfully remain on the UK market, what can companies do if their product doesn't make the list? Barrister Jonathan Kirk QC set out the limited options left open to firms during a recent webinar.

Kyowa Hakko unveils supplement ingredient Eyemuse, a heat-treated “paraprobiotic” found to reduce eye fatigue, filter blue light and support a balanced immune response. CRN campaign educates retailers, consumers about probiotics and helps retailers improve handling of the products.

LanesHealth's UK supplement brands Pro Plus and Gopo get on-trend line extenstions in the areas of cognitive health and natural medicinal alternatives. 

Wellness products accounted for the highest number of launches among health, wellness and beauty products at independent pharmacies in 2020. But the overall number slumped 21.1% due to the pandemic, according to Hamacher Resource Group’s report on a product rating system.

The OTC Marketing Awards 2021 will now take place on 1 December, with entries invited from activity in 2020 and 2021. A special award – Best COVID-19 initiative by an OTC Company – will also recognize the efforts made by the British consumer healthcare industry during the COVID-19 pandemic.

Bayer Consumer Health claims UK OTC industry first with "actionable ad" for its Berocca Boost dispersible vitamin and mineral supplement. 

Emerging markets expected to be growth drivers across C&D’s supplement, OTC drug and household care product lines in 2021. Super Immune formulation with more than 100% daily value of vitamin C, zinc and elderberry and Manuka honey is first vitafusion product in cough/cold aisle and brand's first extension for 2021.

“We firmly believe NAD misunderstood the law and applied the wrong legal standard” says Kirk Jowers, doTerra’s corporate relations chief. But the firm “has little recourse but to comply.”

Direct Selling Self-Regulatory Council say after UWell Life didn’t respond to its requests to substantiate ad claims made online for Primocyn brand topicals, the council submitted to its concerns to the FTC.

Pharmavite challenged express and implied claims Goli used online and in social media promoting its product's benefits for weight loss, appetite satiety and craving, heart health, immune, energy, complexion, digestion, bloating, indigestion, heartburn and detoxification.